These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16614140)

  • 1. Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells.
    Moon SO; Kim W; Sung MJ; Lee S; Kang KP; Kim DH; Lee SY; So JN; Park SK
    Mol Pharmacol; 2006 Jul; 70(1):112-9. PubMed ID: 16614140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of alpha-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression.
    Sung MJ; Kim W; Ahn SY; Cho CH; Koh GY; Moon SO; Kim DH; Lee S; Kang KP; Jang KY; Park SK
    Circ Res; 2005 Oct; 97(9):880-90. PubMed ID: 16166554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.
    Chandrasekar B; Mummidi S; Perla RP; Bysani S; Dulin NO; Liu F; Melby PC
    Biochem J; 2003 Jul; 373(Pt 2):547-58. PubMed ID: 12729461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression.
    Ahn SY; Cho CH; Park KG; Lee HJ; Lee S; Park SK; Lee IK; Koh GY
    Am J Pathol; 2004 May; 164(5):1663-72. PubMed ID: 15111313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: down-regulation by cAMP.
    Chen YM; Lin SL; Chen CW; Chiang WC; Tsai TJ; Hsieh BS
    Kidney Int; 2003 Feb; 63(2):474-86. PubMed ID: 12631113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein suppression of TNF-alpha-induced fractalkine expression in endothelial cells.
    Sung MJ; Kim DH; Davaatseren M; Hur HJ; Kim W; Jung YJ; Park SK; Kwon DY
    Cell Physiol Biochem; 2010; 26(3):431-40. PubMed ID: 20798528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
    Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y
    Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin inhibits tumor necrosis factor-alpha-stimulated fractalkine expression in human umbilical vein endothelial cells.
    Jiang DQ; Liu H; Zhang SB; Zhang XL
    Chin Med J (Engl); 2009 May; 122(10):1147-53. PubMed ID: 19493461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
    Fang IM; Lin CP; Yang CM; Chen MS; Yang CH
    Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
    Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
    Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
    Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
    Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions.
    Ancuta P; Moses A; Gabuzda D
    Immunobiology; 2004; 209(1-2):11-20. PubMed ID: 15481136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
    Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
    Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractalkine expression in the rhesus monkey brain during lentivirus infection and its control by 6-chloro-2',3'-dideoxyguanosine.
    Depboylu C; Eiden LE; Schäfer MK; Reinhart TA; Mitsuya H; Schall TJ; Weihe E
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1170-80. PubMed ID: 17146291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys.
    Kikuchi Y; Ikee R; Hemmi N; Hyodo N; Saigusa T; Namikoshi T; Yamada M; Suzuki S; Miura S
    Nephron Exp Nephrol; 2004; 97(1):e17-25. PubMed ID: 15153757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II.
    Rius C; Piqueras L; González-Navarro H; Albertos F; Company C; López-Ginés C; Ludwig A; Blanes JI; Morcillo EJ; Sanz MJ
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):96-104. PubMed ID: 23117657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viscolin reduces VCAM-1 expression in TNF-α-treated endothelial cells via the JNK/NF-κB and ROS pathway.
    Liang CJ; Wang SH; Chen YH; Chang SS; Hwang TL; Leu YL; Tseng YC; Li CY; Chen YL
    Free Radic Biol Med; 2011 Oct; 51(7):1337-46. PubMed ID: 21767632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
    Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
    Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.